32888-88-3 Usage
General Description
2-AMINO-5-CHLORO-1,4-BENZENEDICARBOXYLIC ACID, also known as 5-Chlorophthaloyl Glycine, is a chemical compound that contains an amino group and a chlorine atom attached to a benzene ring with two carboxylic acid groups. It is often used as a building block in the synthesis of pharmaceutical drugs and agrochemicals. 2-AMINO-5-CHLORO-1,4-BENZENEDICARBOXYLIC ACID has potential applications in the field of medicine as it can be used as a precursor in the manufacturing of various pharmaceuticals. Additionally, its unique chemical structure makes it useful in the creation of specialized polymers and materials. However, it is important to handle this chemical with care, as it can be toxic if ingested or inhaled and can cause skin and eye irritation.
Check Digit Verification of cas no
The CAS Registry Mumber 32888-88-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,8,8 and 8 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 32888-88:
(7*3)+(6*2)+(5*8)+(4*8)+(3*8)+(2*8)+(1*8)=153
153 % 10 = 3
So 32888-88-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H6ClNO4/c9-5-1-4(8(13)14)6(10)2-3(5)7(11)12/h1-2H,10H2,(H,11,12)(H,13,14)
32888-88-3Relevant articles and documents
Effect of the Metal within Regioisomeric Paddle-Wheel-Type Metal–Organic Frameworks
Ha, Hyeonbin,Kim, Youngik,Kim, Dopil,Lee, Jihyun,Song, Yoodae,Kim, Suyeon,Park, Myung Hwan,Kim, Youngjo,Kim, Hyungjun,Yoon, Minyoung,Kim, Min
supporting information, p. 14414 - 14420 (2019/11/03)
The effect of metal on the degree of flexibility upon evacuation of metal–organic frameworks (MOFs) has been revealed with positional control of the organic functionalities. Although Co-, Cu-, and Zn-based DMOFs (DMOF = DABCO MOF, DABCO = 1,4-diazabicyclo
PROLYL HYDROXYLASE INHIBITORS
-
Page/Page column 25-26, (2010/07/10)
The invention described herein relates to certain 2,4-dioxo-l,2,3,4-tetrahydro-7- quinazolinecarboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.